Marker Therapeutics Inc (MRKR)

[MasterSalix]

But seriously, with $20M they should have the funding necessary to develop to the stage where dilutive funding is no longer necessary for the later development. I have looked at the numbers and read all the filings (unlike you, obviously ) I see where management is going - if they can do it ( big if ) and not have to issue 50M + to do it, I think it is a very positive move LT.